NASDAQ:ABAX - Nasdaq - US0025671050
Margin of Safety Calculated for NASDAQ:ABAX | Healthcare, News, Safe Dividend
The S&P 600 small-cap health-care sector is up 36% this year.
Mentions: ZTS
Zoetis wants to grab a larger share of the veterinary diagnostics market with its acquisition of Abaxis.
Mentions: ZTS
Here's how to start investing in the $100 billion pet care industry. US News and World Report reports.
Mentions: ZTS
ABAX – Sidoti reiterates Neutral rating. Stock price at the time of this analyst call was $83.24.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on May 17) Abaxis Inc (NASDAQ: ABAX) (...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech Stocks Hitting 52-week highs on May 16) Abaxis Inc (NASDAQ...
ABAX – Credit Suisse upgrades to Neutral from Underperform. Stock price at the time of this analyst call was $71.75.
Find out which of these stocks got a buyout bid.
Mentions: BOOT
Pharmaceutical company Zoetis said Wednesday it will acquire Abaxis for nearly $2 billion — propelling Abaxis stock by double digits in premarket trading.
Mentions: ZTS
Abaxis (ABAX) stock was flying high Wednesday on news that Zoetis (ZTS) is acquiring it for $2.00 billion, or $83 per share.
Mentions: ZTS
Zoetis Inc. and Abaxis, Inc. announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis for $83 per share in cash, or approximately $2B in aggregate.
Mentions: ZTS
Pharmaceutical company Zoetis said Wednesday it will acquire Abaxis for nearly $2 billion — propelling Abaxis stock by double digits in premarket trading.
Mentions: ZTS
ABAX – Sidoti downgrades to Neutral from Buy. Stock price at the time of this analyst call was $71.75.
Animal health company Zoetis said it would buy Abaxis, a maker of veterinary diagnostic instruments, for about $1.9 billion in cash.
Mentions: ZTS
Some of the names on the move ahead of the open.
ABAX – Abaxis to be acquired by Zoetis for $83 per share in cash, or approximately $2.0 billion.
Mentions: ZTS